Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 CD19 is a useful B cell marker after treatment with rituximab: comment on the article by Jones et al.

× No keyword cloud information.

5 in total

1. Refractory Autoimmune Hepatitis: Beyond Standard Therapy.

Authors: Jonah N Rubin; Helen S Te
Journal: Dig Dis Sci Date: 2016-01-02 Impact factor: 3.199

2. Extra-central nervous system target for assessment and treatment in refractory anti-N-methyl-d-aspartate receptor encephalitis.

Authors: David W Nauen
Journal: J Crit Care Date: 2016-09-22 Impact factor: 3.425

3. Phase IIa study of the CD19 antibody MOR208 in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma.

Authors: W Jurczak; P L Zinzani; G Gaidano; A Goy; M Provencio; Z Nagy; T Robak; K Maddocks; C Buske; S Ambarkhane; M Winderlich; M Dirnberger-Hertweck; R Korolkiewicz; K A Blum
Journal: Ann Oncol Date: 2018-05-01 Impact factor: 32.976

4. Efficacy and safety of rituximab in childhood-onset, difficult-to-treat nephrotic syndrome: A multicenter open-label trial in Korea.

Authors: Yo Han Ahn; Seong Heon Kim; Kyoung Hee Han; Hyun Jin Choi; Heeyeon Cho; Jung Won Lee; Jae Il Shin; Min Hyun Cho; Joo Hoon Lee; Young Seo Park; Il-Soo Ha; Hae Il Cheong; Su Young Kim; Seung Joo Lee; Hee Gyung Kang
Journal: Medicine (Baltimore) Date: 2018-11 Impact factor: 1.817

5. Complement-Dependent Activity of CD20-Specific IgG Correlates With Bivalent Antigen Binding and C1q Binding Strength.

Authors: Sina Bondza; Anita Marosan; Sibel Kara; Josephine Lösing; Matthias Peipp; Falk Nimmerjahn; Jos Buijs; Anja Lux
Journal: Front Immunol Date: 2021-01-11 Impact factor: 7.561

5 in total